C. Stephen Foster, M.D.
In Print (651-700)
651. Cervantes-Castañeda R, Bhat P, Fortuna E, Acevedo, Foster CS. Induction of Durable Remission in Ocular Inflammatory Diseases. European Journal of Ophthalmology. 2009 Jan-Feb;19(1):118-23.
652. Fiore T, Iaccheri B, Androudi S, Anzaar F, D’ Amico DJ, Foster CS. Acute posterior multifocal placoid pigment epitheliopathy: outcome and visual prognosis. 2009 Jul-Aug; 29(7):994-1001.
653. Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Suhler EB. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. 2009 Oct;148(4):500-509.e2. Epub 2009 Jul 1.
654. Bhat P, Cervantes-Castaneda RA, Doctor PP, Anzaar F, Foster CS. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm. 2009 May- June;17(3): 185-90.
655. Mauro J, Foster CS. Pterygia: Pathogenesis and the role of the subconjunctival bevacizumab in treatment. Semin Ophthalmol. 2009 May-June;24(3): 130-4.
656. Kempen JH, Daniel E, Dunn JP, et al. Risk of overall and cancer mortality among patients with ocular inflammation treated with immunosuppressive therapy: retrospective cohort study. Brit Med J. 2009 Jul 3;330.
657. Bhat PV, Jakobiec FA, Kurbanyan K, Zhao T, Foster CS. Chronic Herpes Simplex Scleritis: Characterization of 9 Cases of Underrecognized Clinical Entitiy. Am J Ophthalmol. 2009 Aug 10.
658. Giuliari GP, Hinkle DM, Foster CS. Local treatment for lymphoid malignancies of the eye. Anticancer Agents Med Chem. 2009 Dec;9(10):1123-8. Review.
659. Zakka FR, Chang PY, Giuliari GP, Foster CS. Current trends in the management of ocular symptoms in Adamantiades-Behçet’s disease. Clin Ophthalmol. 2009;3:567-79. Epub 2009 Oct 19.
660. Pe’er J, Hochberg FH, Foster CS. Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm. 2009 Sep-Oct;17(5):299-306. Review.
661. Doctor P, Sultan A, Syed S, Christen W, Bhat P, Foster CS. Infliximab for the treatment of refractory scleritis. Br J Ophthalmol. 2010 May;94(5):579-83. Epub 2009 Dec 2.
662. Papadaki T, Iaccheri B, Fiore T, Zacharopoulos I, Thadani S, Christen W, Androudi S, Foster CS. Serum soluble interleukin-2 receptor levels do not correlate with an associated systemic disease in patients with uveitis. Acta Ophthalmol. 2010 Mar;88(2):e28-9. Epub 2009 Jun 2.
663. Jancevski M, Foster CS. Cataracts and uveitis. Discov Med. 2010 Jan;9(44):51-4.
664. Gangaputra S, Newcomb CW, Liesegang TL, Kacmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort St Ophthalmology. Methotrexate for ocular inflammatory disease. 2009 Nov;116(11):2188-98.e1.
665. Kaçmaz RO, Kempen JH, Newcomb C, Daniel E, Gangaputra S, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Foster CS. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010 Mar;117(3):576-84. Epub 2010 Jan 19.
666. Giuliari GP, Chang PY, Thakuria P, Hinkle DM, Foster CS. Pars plana vitrectomy in the management of paediatric uveitis: the Massachusetts Eye Research and Surgery Institution experience. Eye (Lond). 2010 Jan;24(1):7-13. Epub 2010 Jan 8. Erratum in: Eye (Lond). 2010 May;24(5):946
667. Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010 Mar;149(3):423-32.e1-2. Epub 2009 Dec 30.
668. Watkins AS, Kempen JH, Choi D, Liesegang TL, Pujari SS, Newcomb C, Nussenblatt RB, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Suhler EB, Smith JR. Ocular disease in patients with ANCA-positive vasculitis. J Ocul Biol Dis Infor. 2009 Dec 12;3(1):12-19.
669. Jancevski M, Foster CS. Cataracts and uveitis. Discov Med. 2010 Jan;9(44):51-4.
670. Ceron OM, Hinkle DM, Foster CS. Intraocular Inflammatory Disorders Update. Retinal Physician. 2009 Feb:24-8.
671. Foster CS, Chang PY, Ahmed AR. Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report. Ophthalmology. 2010 May;117(5):861-9. Epub 2010 Jan 4.
672. Giuliari G, Hinkle DM, Foster CS. The spectrum of fundus autofluorescence findings in birdshot chorioretinopathy. J Ophthalmol. 2009;2009:567693. Epub 2010 Feb 8.
673. Amorese L, Foster CS. Parasitic Keratitis. Contemporary Ophthalmology. 2010 Jan 15.
674. Multicenter Uveitis Steroid Treatment Trial Research Group. The Multicenter Uveitis Steroid Treatment (MUST) Trial: Rationale, Design and Baseline Characteristics. Am J Ophthalmol 2010;149:550-561. e10. Epub 2010 Jan 25.
675. Pujari SS, Kempen JH, Newcomb CW, Gangaputra S, Daniel E, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Foster CS. Cyclophosphamide for ocular inflammatory diseases. Ophthalmology. 2010 Feb;117(2):356-65. Epub 2009 Dec 6.
676. Zaidi AA, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Kempen JH. Hypopyon in patients with uveitis. Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Ophthalmology. 2010 Feb;117(2):366-72. Epub 2009 Dec 14.
677. Tumalad M, Mansoor A, Foster CS. Ocular Manifestations of Herpes Simplex Virus Infection. Contemporary Ophthalmology. 2010 Feb 28.
678. Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010 Mar;149(3):423-32.e1-2
679. Fiorelli VM, Bhat P, Foster CS. Nonsteroidal anti-inflammatory therapy and recurrent acute anterior uveitis. Ocul Immunol Inflamm. 2010 Apr;18(2):116-20.
680. Durrani K, Foster CS. Management of Uveitis: Current concepts and modalitites. Contemporary Ophthalmology. 2010 Apr 30.
681. Lee F, Foster CS. Pharmacotherapy of Uveitis. Expert Opinion on Pharmacotherapy. 2010 May;11(7):1135-46.
682. Masood K, Foster CS. Birdshot Retinochoroidopathy: An Updated Review of Diagnosis, Treatment, and Management Options. Contemporary Ophthalmology. 2010 May 15.
683. Siddique SS, Foster CS. Central Serous Chorioretinopathy. Contemporary Ophthalmology. 2010 Jun 15.
684. Galor A, Feuer W, Kempen JH, Kaçmaz RO, Liesegang TL, Suhler EB, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Thorne JE. Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol. 2010 Jul;94(7):848-53.
685. Portero-Benito A, Foster CS. Ocular Albinism. Contemporary Ophthalmology. 2010 Jul 15.
686. Mehta M, Foster CS. Histopathologic Differential Diagnosis of Common Eyelid Lesions. Contemporary Ophthalmology. 2010 Jul 30.
687. Giuliari GP, Pujari S, Shaikh M, Marvell D, Foster CS. Microperimetry findings in patients with birdshot chorioretinopathy. Can J Ophthalmol. 2010 Aug;45(4):399-403.
688. Ciralsky J, Papaliodis GN, Foster CS, Dohlman CH, Chodosh J. Keratoprosthesis in autoimmune disease. Ocul Immunol Inflamm. 2010 Aug;18(4):275-80.
689. Villaneuva- Palafox SK, Shaikh M, Foster CS. Neuromyelitis Optica (Devic’s Disease) : An entity distinct from multiple sclerosis. Contemporary Ophthalmology. 2010 Aug 15.
690. Foster CS, Davanzo R, Flynn TE, McLeod K, Vogel R, Crockett RS. Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis. J Ocul Pharmacol Ther. 2010 Oct;26(5):475-83.
691. Mehta M, Dacey M, Stephen Foster C. Recurrent conjunctivitis and scleritis secondary to coexistent conjunctival pemiphigus vulgaris and cryptic herpes simplex infection: a case report. Ocul Immunol Inflamm. 2010 Dec;18(6):454-6. Epub 2010 Sep 2.
692. Siddique SS, Gonzalez-Gonzalez LA, Thakuria P, Chang PY, Foster CS. Scleral necrosis in a patient with congenital erythropoietic porphyria. Cornea. 2011 Jan;30(1):97-9.
693. Quinones K, Choi JY, Yilmaz T, Kafkala C, Letko E, Foster CS. Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study. Ocul Immunol Inflamm. 2010 Oct;18(5):411-7.
694. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH; Psoriasis Study Group, Durez P, Tak PP, Gomez-Reino JJ; Rheumatoid Arthritis Study Group, Foster CS, Kim RY, Samson CM, Falk NS, Chu DS, Callanan D, Nguyen QD; Uveitis Study Group, Rose K, Haider A, Di Padova F. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med. 2010 Oct 6.
695. Krader CG, Foster CS. Dexamethasone Implant an Option For Posterior Segment Uveitis. Ophthalmology Times. 2010 Oct 15; 35 (20): 1, 11.
696. Siddique SS, Gonzalez-Gonzalez LA, Amorese L, Shaikh M, Foster S. Herpes keratitis in a patient undergoing treatment with topical mitomycin C. Cornea. 2011 Apr;30(4):466-7.
697. Jancevski M, Foster CS. Anterior segment optical coherence tomography. Semin Ophthalmol. 2010 Sep-Nov;25.
698. Foster CS, Anesi S. The Successful Approach to Ocular Rosacea. Drugs and Disease, Refractive Eyecare. Dec 2010: 11-12, 19.
699. Lowder C, Belfort R Jr, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM; Ozurdex HURON Study Group. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol. 2011 May;129(5):545-53. Epub 2011 Jan 10.
700. Palafox SK, Smitha J, Tauber A, Foster CS. Ophthalmia Neonatorum. Journal of Clinical & Experimental Ophthalmology 2:119 (1-5).
 |
|
|
|
